These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9080864)

  • 1. Which device should "MADIT protocol" patients receive? Multicenter Automatic Defibrillator Implantation Trial.
    Higgins SL; Klein H; Nisam S
    Am J Cardiol; 1997 Mar; 79(6A):31-5. PubMed ID: 9080864
    [No Abstract]   [Full Text] [Related]  

  • 2. MADIT II (second Multicenter Automated Defibrillator Implantation Trial) debate: risk stratification, costs, and public policy.
    Reynolds MR; Josephson ME
    Circulation; 2003 Oct; 108(15):1779-83. PubMed ID: 14557341
    [No Abstract]   [Full Text] [Related]  

  • 3. Do MADIT results apply only to "MADIT patients"? Multicenter Automatic Defibrillator Implantation Trial.
    Nisam S
    Am J Cardiol; 1997 Mar; 79(6A):27-30. PubMed ID: 9080863
    [No Abstract]   [Full Text] [Related]  

  • 4. The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
    Zwanziger J; Hall WJ; Dick AW; Zhao H; Mushlin AI; Hahn RM; Wang H; Andrews ML; Mooney C; Wang H; Moss AJ
    J Am Coll Cardiol; 2006 Jun; 47(11):2310-8. PubMed ID: 16750701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Multicenter Automatic Defibrillator Implantation Trial.
    Mushlin AI; Hall WJ; Zwanziger J; Gajary E; Andrews M; Marron R; Zou KH; Moss AJ
    Circulation; 1998 Jun; 97(21):2129-35. PubMed ID: 9626173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of the implantable cardioverter-defibrillator: better in higher-risk patients and extended duration.
    Amsterdam EA
    Prev Cardiol; 2006; 9(3):131-2. PubMed ID: 16849874
    [No Abstract]   [Full Text] [Related]  

  • 7. The implantable cardioverter defibrillator and primary prevention of sudden death: the Multicenter Automatic Defibrillator Implantation Trial and the Coronary Artery Bypass Graft (CABG)-Patch Trial.
    Block M; Breithardt G
    Am J Cardiol; 1999 Mar; 83(5B):74D-78D. PubMed ID: 10089844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic implantable cardioverter defibrillator trials: MUSTT, MADIT, and beyond. Multicenter Unsustained Tachycardia Trial. Multicenter Automatic Defibrillator Implantation Trial.
    Prystowsky EN; Nisam S
    Am J Cardiol; 2000 Dec; 86(11):1214-5, A5. PubMed ID: 11090794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II.
    Al-Khatib SM; Anstrom KJ; Eisenstein EL; Peterson ED; Jollis JG; Mark DB; Li Y; O'Connor CM; Shaw LK; Califf RM
    Ann Intern Med; 2005 Apr; 142(8):593-600. PubMed ID: 15838065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of implantable cardioverter-defibrillators.
    Sanders GD; Hlatky MA; Owens DK
    N Engl J Med; 2005 Oct; 353(14):1471-80. PubMed ID: 16207849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The MADIT-RIT study].
    Proclemer A; Locati ET
    G Ital Cardiol (Rome); 2013 Apr; 14(4):241-5. PubMed ID: 23567763
    [No Abstract]   [Full Text] [Related]  

  • 12. MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials?
    Coats AJ
    Int J Cardiol; 2002 Jan; 82(1):1-5. PubMed ID: 11786150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
    Ruwald AC; Pietrasik G; Goldenberg I; Kutyifa V; Daubert JP; Ruwald MH; Jons C; McNitt S; Wang P; Zareba W; Moss AJ
    J Am Coll Cardiol; 2014 Apr; 63(12):1190-1197. PubMed ID: 24333490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of the risk of recurring heart failure events with cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
    Goldenberg I; Hall WJ; Beck CA; Moss AJ; Barsheshet A; McNitt S; Polonsky S; Brown MW; Zareba W
    J Am Coll Cardiol; 2011 Aug; 58(7):729-37. PubMed ID: 21816309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).
    Zareba W; Piotrowicz K; McNitt S; Moss AJ;
    Am J Cardiol; 2005 Jun; 95(12):1487-91. PubMed ID: 15950580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of implantable cardioverter-defibrillator in reducing total mortality in the high-risk coronary patient.
    Mower MM
    Md Med J; 1997 Feb; 46(2):75-8. PubMed ID: 9029905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approach to cost-effectiveness assessment in the MADIT trial. Multicenter Automatic Defibrillator Implantation Trial.
    Mushlin AI; Zwanziger J; Gajary E; Andrews M; Marron R
    Am J Cardiol; 1997 Sep; 80(5B):33F-41F. PubMed ID: 9291448
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost advantage of different cardioverter-defibrillator devices.
    Veenhuyzen GD
    J Am Coll Cardiol; 2006 Jul; 48(2):418-9; author reply 419. PubMed ID: 16843205
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.
    Chan PS; Stein K; Chow T; Fendrick M; Bigger JT; Vijan S
    J Am Coll Cardiol; 2006 Jul; 48(1):112-21. PubMed ID: 16814657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Special report: cost-effectiveness of implantable cardioverter-defibrillators in a MADIT-II population.
    Technol Eval Cent Assess Program Exec Summ; 2004 Apr; 19(3):1-2. PubMed ID: 15314827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.